World Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $320K | Sell |
1,694
-160
| -9% | -$30.2K | 0.03% | 586 |
|
|
2021
Q2 | $314K | Sell |
1,854
-131
| -7% | -$22.2K | 0.03% | 653 |
|
|
2021
Q1 | $279K | Sell |
1,985
-156
| -7% | -$21.9K | 0.03% | 713 |
|
|
2020
Q4 | $278K | Buy |
2,141
+65
| +3% | +$8.44K | 0.03% | 678 |
|
|
2020
Q3 | $302K | Buy |
2,076
+17
| +0.8% | +$2.47K | 0.03% | 548 |
|
|
2020
Q2 | $305K | Buy |
2,059
+75
| +4% | +$11.1K | 0.03% | 526 |
|
|
2020
Q1 | $216K | Sell |
1,984
-898
| -31% | -$97.8K | 0.02% | 734 |
|
|
2019
Q4 | $332K | Sell |
2,882
-527
| -15% | -$60.7K | 0.02% | 764 |
|
|
2019
Q3 | $274K | Buy |
3,409
+219
| +7% | +$17.6K | 0.01% | 873 |
|
|
2019
Q2 | $231K | Buy |
3,190
+180
| +6% | +$13K | 0.01% | 983 |
|
|
2019
Q1 | $281K | Buy |
3,010
+78
| +3% | +$7.28K | 0.01% | 873 |
|
|
2018
Q4 | $214K | Sell |
2,932
-153
| -5% | -$11.2K | 0.01% | 915 |
|
|
2018
Q3 | $270K | Buy |
3,085
+99
| +3% | +$8.67K | 0.01% | 991 |
|
|
2018
Q2 | $294K | Sell |
2,986
-12
| -0.4% | -$1.18K | 0.01% | 968 |
|
|
2018
Q1 | $357K | Sell |
2,998
-696
| -19% | -$82.9K | 0.02% | 913 |
|
|
2017
Q4 | $469K | Buy |
3,694
+209
| +6% | +$26.5K | 0.02% | 905 |
|
|
2017
Q3 | $409K | Buy |
3,485
+14
| +0.4% | +$1.64K | 0.01% | 966 |
|
|
2017
Q2 | $277K | Buy |
+3,471
| New | +$277K | 0.01% | 1150 |
|
|
2015
Q2 | – | Sell |
-2,277
| Closed | -$238K | – | 1151 |
|
|
2015
Q1 | $238K | Buy |
2,277
+71
| +3% | +$7.42K | 0.01% | 1195 |
|
|
2014
Q4 | $214K | Sell |
2,206
-728
| -25% | -$70.6K | 0.01% | 1242 |
|
|
2014
Q3 | $229K | Buy |
+2,934
| New | +$229K | 0.01% | 1272 |
|
|
2013
Q4 | – | Sell |
-4,195
| Closed | -$269K | – | 1571 |
|
|
2013
Q3 | $269K | Buy |
+4,195
| New | +$269K | 0.01% | 1352 |
|